Tillman U. Gerngross - Insider Trading & Ownership

Location
C/O Arsanis, Inc., 890 Winter Street, Suite 230, Waltham, MA
Summary
The estimated net worth of Tillman U. Gerngross is at least $125M dollars as of June 15, 2023. Tillman U. Gerngross is the Chief Executive Officer, Director, 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $110M. Tillman U. Gerngross is the Director of Alector, Inc. and owns shares of Alector, Inc. (ALEC) stock worth about $14.7M.
Signature
/s/ Marc Grasso, by power of attorney
All Insider Reports
All Insider Reports

Ownership of Tillman U. Gerngross

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IVVD Invivyd, Inc. Chief Executive Officer, Director, 10%+ Owner $110M Jan 30, 2022
ALEC Alector, Inc. Director $14.7M Jun 14, 2023

Insider Transactions Reported by Tillman U. Gerngross:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.